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Identity 
Other names: ERK3; PRKM6; p97MAPK 
HGNC (Hugo): MAPK6 
Location: 15q21.2 
Local order: The MAPK6 gene is located between the 
genes LEO1 and BCL2L10 on chromosome 15. 
DNA/RNA 
Description 
The MAPK6 gene spans 47.01 kb on the long arm of 
chromosome 15 and is transcribed in the centromere-
to-telomere orientation. The gene is composed of 6 
exons with the translation initiation codon located in 
exon 2. The first two exons are separated by a long 
intron of 26.45 kb. 
Transcription 
The MAPK6 transcribed mRNA has 4,186 bp. No 
splice variants have been reported. 
Pseudogene 
Database analysis reveals the presence of six MAPK6 
pseudogenes localized on four different chromosomes: 
MAPK6PS1 (8q11.23), MAPK6PS2 (21q21.1), 
MAPK6PS3 (13q14.13), MAPK6PS4 (8q11.1), 
MAPK6PS5 (8q23.1) and MAPK6PS6 (10q11.23). All 
six loci contain intronless copies of MAPK6 and 
display the features of processed pseudogenes. 
Protein 
Description 
Extracellular signal-regulated kinase 3 (ERK3) is an 
atypical member of the mitogen-activated protein 
(MAP) kinase family of serine/threonine kinases. The 
human ERK3 protein is made of 721 amino acids and 
contains a typical kinase domain located at the N-
terminal extremity. Another region with homology to 
the MAP kinase ERK4 (C34 domain) has been 
identified after the kinase domain. The function of the 
C34 domain is unknown. 
Expression 
MAPK6 mRNA is expressed ubiquitously. The highest 
levels of expression are observed in the skeletal muscle 
and brain. ERK3 is a highly unstable protein, with a 
half-life of less than one hour, that is constitutively 
degraded by the ubiquitin-proteasome pathway. 
Notably, oncogenic B-Raf signaling markedly up-
regulates MAPK6 mRNA and protein levels. 
Localisation 
ERK3 localizes to the cytoplasm and nucleus of a 
variety of cultured cells. 
 
Genomic organization of the MAPK6 gene on chromosome 15. 
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Schematic representation of the ERK3 protein structure. Kinase, catalytic kinase domain; C34 conserved region in ERK3 and ERK4; 
SEG, activation loop motif containing the regulatory phosphorylation residue Ser189. 
 
Function 
Little is known about the regulation and functions of 
ERK3. Overexpression of ERK3 in fibroblasts inhibits 
S-phase entry, suggesting that ERK3 may act as a 
negative regulator of cell proliferation in certain 
cellular contexts. The only known physiological 
substrate of ERK3 is the protein kinase MK5. 
Homology 
ERK3 display 73% amino acid identity with ERK4 in 
the kinase domain. ERK4 and ERK3 define a distinct 








DNA microarray studies have yielded conflicting data 
about the regulation of MAPK6 expression in cancer. 
Studies have shown that expression of MAPK6 mRNA 
is down-regulated in brain tumors, ovarian carcinoma 
and cutaneous melanoma, and up-regulated in 
leukemias, adrenocortical carcinoma, squamous cell 
lung carcinoma, salivary adenoid cystic carcinoma, 
tongue squamous cell carcinoma and cervical cancer. In 
prostate cancer, one study reported an inverse 
correlation between MAPK6 mRNA levels and the 
stage of the disease. 
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